Immatics NV Net Income
| IMTX Stock | USD 9.93 0.37 3.59% |
As of the 11th of February 2026, Immatics retains the Market Risk Adjusted Performance of 0.2301, risk adjusted performance of 0.0533, and Downside Deviation of 4.24. Immatics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immatics Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 8.0179 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 17.5 M | 18.4 M | |
| Net Income Applicable To Common Shares | 43.1 M | 45.3 M | |
| Net Income | 17.5 M | 18.4 M | |
| Net Income Per Share | 0.14 | 0.13 | |
| Net Income Per E B T | 0.82 | 1.02 |
Immatics | Net Income | Build AI portfolio with Immatics Stock |
The evolution of Net Income for Immatics NV provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Immatics compares to historical norms and industry peers.
Latest Immatics' Net Income Growth Pattern
Below is the plot of the Net Income of Immatics NV over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Immatics NV financial statement analysis. It represents the amount of money remaining after all of Immatics NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Immatics' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 15.22 M | 10 Years Trend |
|
Net Income |
| Timeline |
Immatics Net Income Regression Statistics
| Arithmetic Mean | (38,090,092) | |
| Coefficient Of Variation | (158.84) | |
| Mean Deviation | 36,133,262 | |
| Median | (31,444,000) | |
| Standard Deviation | 60,502,709 | |
| Sample Variance | 3660.6T | |
| Range | 266.9M | |
| R-Value | 0.08 | |
| Mean Square Error | 3880.7T | |
| R-Squared | 0.01 | |
| Significance | 0.77 | |
| Slope | 936,933 | |
| Total Sum of Squares | 58569.2T |
Immatics Net Income History
Other Fundumenentals of Immatics NV
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Immatics Net Income component correlations
Immatics Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Immatics is extremely important. It helps to project a fair market value of Immatics Stock properly, considering its historical fundamentals such as Net Income. Since Immatics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immatics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immatics' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. Market participants price Immatics higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immatics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.10) | Revenue Per Share | Quarterly Revenue Growth (0.90) | Return On Assets | Return On Equity |
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Immatics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Immatics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immatics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immatics.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Immatics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Immatics NV or generate 0.0% return on investment in Immatics over 90 days. Immatics is related to or competes with Inhibrx Biosciences, Enliven Therapeutics, Nektar Therapeutics, Terns Pharmaceuticals, Relay Therapeutics, Syndax Pharmaceuticals, and ATAI Life. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor b... More
Immatics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immatics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immatics NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.24 | |||
| Information Ratio | 0.0373 | |||
| Maximum Drawdown | 30.34 | |||
| Value At Risk | (6.70) | |||
| Potential Upside | 8.98 |
Immatics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immatics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immatics' standard deviation. In reality, there are many statistical measures that can use Immatics historical prices to predict the future Immatics' volatility.| Risk Adjusted Performance | 0.0533 | |||
| Jensen Alpha | 0.166 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0432 | |||
| Treynor Ratio | 0.2201 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immatics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immatics February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0533 | |||
| Market Risk Adjusted Performance | 0.2301 | |||
| Mean Deviation | 3.36 | |||
| Semi Deviation | 4.03 | |||
| Downside Deviation | 4.24 | |||
| Coefficient Of Variation | 1780.07 | |||
| Standard Deviation | 4.91 | |||
| Variance | 24.1 | |||
| Information Ratio | 0.0373 | |||
| Jensen Alpha | 0.166 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0432 | |||
| Treynor Ratio | 0.2201 | |||
| Maximum Drawdown | 30.34 | |||
| Value At Risk | (6.70) | |||
| Potential Upside | 8.98 | |||
| Downside Variance | 18.01 | |||
| Semi Variance | 16.23 | |||
| Expected Short fall | (3.97) | |||
| Skewness | 0.6625 | |||
| Kurtosis | 2.73 |
Immatics NV Backtested Returns
At this stage we consider Immatics Stock to be somewhat reliable. Immatics NV holds Efficiency (Sharpe) Ratio of 0.0207, which attests that the entity had a 0.0207 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Immatics NV, which you can use to evaluate the volatility of the firm. Please check out Immatics' Downside Deviation of 4.24, risk adjusted performance of 0.0533, and Market Risk Adjusted Performance of 0.2301 to validate if the risk estimate we provide is consistent with the expected return of 0.0953%. Immatics has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.21, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immatics will likely underperform. Immatics NV right now retains a risk of 4.61%. Please check out Immatics maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Immatics will be following its current trending patterns.
Auto-correlation | -0.33 |
Poor reverse predictability
Immatics NV has poor reverse predictability. Overlapping area represents the amount of predictability between Immatics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immatics NV price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Immatics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Immatics Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Immatics NV reported net income of 15.22 M. This is 95.54% lower than that of the Biotechnology sector and 78.27% lower than that of the Health Care industry. The net income for all United States stocks is 97.33% higher than that of the company.
Immatics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immatics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immatics could also be used in its relative valuation, which is a method of valuing Immatics by comparing valuation metrics of similar companies.Immatics is currently under evaluation in net income category among its peers.
Immatics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immatics from analyzing Immatics' financial statements. These drivers represent accounts that assess Immatics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immatics' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 743.6M | 546.8M | 767.3M | 746.3M | 671.7M | 497.0M | |
| Enterprise Value | 620.4M | 412.8M | 564.3M | 525.8M | 473.2M | 380.3M |
Immatics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Immatics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Immatics' managers, analysts, and investors.Environmental | Governance | Social |
Immatics Institutional Holders
Institutional Holdings refers to the ownership stake in Immatics that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Immatics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immatics' value.| Shares | Sofinnova Ventures | 2025-06-30 | 2.2 M | Goldman Sachs Group Inc | 2025-06-30 | 1 M | Citadel Advisors Llc | 2025-06-30 | 879.2 K | Wasatch Advisors Lp | 2025-06-30 | 785.2 K | Orbimed Advisors, Llc | 2025-06-30 | 719.9 K | Aberdeen Group Plc | 2025-06-30 | 719.6 K | University Of Texas Investment Mgmt Co | 2025-06-30 | 697.4 K | Sphera Funds Management Ltd. | 2025-06-30 | 583.1 K | 683 Capital Management Llc | 2025-06-30 | 540 K | T. Rowe Price Investment Management,inc. | 2025-06-30 | 18.3 M | Suvretta Capital Management, Llc | 2025-06-30 | 12 M |
Immatics Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (1.42) % | ||||
| Operating Margin | (10.53) % | ||||
| Current Valuation | 802.94 M | ||||
| Shares Outstanding | 134.06 M | ||||
| Shares Owned By Insiders | 18.80 % | ||||
| Shares Owned By Institutions | 77.10 % | ||||
| Number Of Shares Shorted | 5.37 M | ||||
| Price To Earning | 44.61 X | ||||
| Price To Book | 2.63 X | ||||
| Price To Sales | 16.29 X | ||||
| Revenue | 155.84 M | ||||
| Gross Profit | (91.28 M) | ||||
| EBITDA | 34.46 M | ||||
| Net Income | 15.22 M | ||||
| Cash And Equivalents | 324.38 M | ||||
| Cash Per Share | 5.00 X | ||||
| Total Debt | 16.2 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 2.95 X | ||||
| Book Value Per Share | 4.05 X | ||||
| Cash Flow From Operations | (158.03 M) | ||||
| Short Ratio | 12.12 X | ||||
| Earnings Per Share | (1.10) X | ||||
| Price To Earnings To Growth | 3.00 X | ||||
| Target Price | 19.13 | ||||
| Number Of Employees | 645 | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 1.38 B | ||||
| Total Asset | 696.15 M | ||||
| Retained Earnings | (589.54 M) | ||||
| Working Capital | 561.57 M | ||||
| Net Asset | 696.15 M |
About Immatics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immatics NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immatics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immatics NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immatics Stock Analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.